Search

everythinglearnresearchcommunity

for

Search:↓

Androgens can cause hair growth in some areas and hair loss on the scalp.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Wounds on the face usually heal with scars, but understanding how some wounds heal without scars could lead to better treatments.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

*Acorus calamus* has many medicinal benefits but needs more safety research.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Herbal nano-formulations show potential for effective skin delivery but need more research.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Finasteride shows promise for female hair loss, but more research needed.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Scalp hair grows at 0.37 mm/day, forearm hair at 0.18 mm/day, and thigh hair at 0.30 mm/day, with no significant differences found in people with certain hair conditions.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.